OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Oncology Hematology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches	230
Navigating management of localized prostate cancer in the geriatric population	160
Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment	126
Editorial Board	121
A bone paradigm challenging the standard model of myeloma oncogenesis	121
Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables accurate diagnosis of cervical cancer: From molecule to cell to tissue level	93
Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?	92
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era	87
The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy	74
Current status of locally advanced rectal cancer therapy and future prospects	73
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients	71
Letter to the Editor regarding the article “A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs app	69
Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis	67
Advancing tumor vaccines: Overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy	65
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting	65
Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: A systematic review	63
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies	60
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials	57
Novel bioengineered drugs with immunotherapies for malignant pleural effusion: Remodulate tumor immune microenvironment and activate immune system	57
Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics	56
A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer	55
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II	53
Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials	48
Stereotactic body radiotherapy as an alternative to brachytherapy in cervical cancer (SCORE): A systematic review and meta-analysis	46
Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions	45

Microbiome Dynamics in Breast Cancer: Mechanisms, Therapeutic Impacts and Research gaps	45
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm	44
Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysis	44
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study	43
Unveiling the Role of JAK2/STAT3 signaling in chemoresistance of gynecological cancers: From mechanisms to therapeutic implications	41
The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth	41
Instruments and scales for the evaluation of acute radiation dermatitis: A systematic review	40
Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models	38
ESO's career development program (2002-2021): Presentation and evaluation	37
Immunotherapy in OSCC: Current trend and challenges	37
TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?	37
The biology and treatment of leiomyosarcomas	36
Editorial Board	36
Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: Recent advancements	36
Impact of immune cells on the hallmarks of cancer: A literature review	36